By Nadine Schimroszik and Arno Schuetze
BERLIN, June 17 (Reuters) - Germany-based laser
communication technologies firm Mynaric M0Y.DE is preparing
for a Nasdaq listing as early as after the summer as it seeks to
broaden its investor base and potentially boost its valuation,
people close to the matter said.
Data centre operator Northern Data NB2.DE , which like
Mynaric is part-owned by technology investor Christian
Angermayer, has similar plans for a Nasdaq listing, which could
take place later in 2021 or in 2022, they added.
While Mynaric is expected to work with Credit Suisse on the
deal, no bank has been shortlisted for the Northern Data
transaction, they added.
Both Northern Data and Mynaric are already listed in entry
segments in Germany, with Northern Data's market capitalisation
standing at 1.3 billion euros ($1.55 billion) and Mynaric's at
300 million euros.
Both companies, Angermayer and Credit Suisse declined to
comment.
The listings would add to a string of deals that have
involved tech entrepreneur Angermayer, including the IPOs of
Sensei Biotherapeutics SNSE.O , Abcellera ABCL.O and Compass
Pathways CMPS.O .
Berlin-based biotech Atai Life Sciences, where Angermayer
holds about 25% of the shares, is due to list on Nasdaq later
this week.
Bookrunners on the deal have guided investors to expect the
initial public offering to price in the upper half of the
marketing range of $13-$15 a share.
Separately, Angermayer has held talks about a potential SPAC
deal for blockchain technology firm Bitfield, although those
negotiations have been placed on the backburner, people close to
that situation said.
SPACs are shell companies that raise funds in an initial
public offering with the aim of merging with a private company,
which becomes public as a result, providing an alternative to
traditional IPOs.
($1 = 0.8379 euros)
(Editing by Elaine Hardcastle)
((arno.schuetze@thomsonreuters.com; +49 30220133648;))